Today: 18 June 2026

ChronoScale Shares Jump After Tesla Alum Joins AI Compute Effort

ChronoScale Shares Jump After Tesla Alum Joins AI Compute Effort

ChronoScale shares soared nearly 18% to $22.43 after appointing ex-Tesla VP Raj Jegannathan as CTO and Lawrence Lam as CPO, just a month after its Nasdaq debut following a merger with Applied Digital’s cloud business and Ekso Bionics; Applied Digital and affiliates hold about 97% of shares, giving the company a $3.21 billion equity value, while investors weigh execution risks and integration challenges.
Blue Owl Shares Rise With Private-Credit Concerns Fading

Blue Owl Shares Rise With Private-Credit Concerns Fading

Blue Owl shares surged 5.5% to $10.225 as private-credit asset managers rebounded after Blackstone capped withdrawals at a major fund, easing investor fears about sector-wide redemption risks; Blue Owl’s own funds previously faced large withdrawal requests, and further negative updates could quickly reverse gains.
4 June 2026
Oscar Health gains after Wells Fargo upgrade

Oscar Health gains after Wells Fargo upgrade

Oscar Health soared 15.5% to $23.68 after Wells Fargo upgraded the stock, citing improved 2026 health-exchange trends despite warning that visibility beyond this year remains low; the move outpaced rivals as traders bet on near-term stability, even as risks from expiring tax credits and policy changes linger.
4 June 2026
Grab Stock Bounces While Nasdaq Sags—What Traders Are Waiting For Next

Grab Stock Bounces While Nasdaq Sags—What Traders Are Waiting For Next

Grab Holdings’ U.S. shares jumped 2.9% to $3.51 as investors weighed strong Q1 results—revenue up 24% to $955 million, adjusted EBITDA up 46% to $154 million—and the consolidation of Indonesia’s Superbank, now majority-owned by Grab, against risks from higher fuel costs and regional regulation, leaving the stock sensitive to further updates on profitability and fintech growth.
Goldman Sachs Jumps as Dow Sets New High

Goldman Sachs Jumps as Dow Sets New High

Goldman Sachs shares surged 4.6% to $1,095.89, powering the Dow to an all-time high as investors rotated into financials; the move was amplified by Goldman’s high share price in the price-weighted Dow, while the bank’s lead role in the $75 billion SpaceX IPO and strong Q1 earnings added momentum, even as analysts flagged risks from high IPO valuations and geopolitical uncertainty.
Veru shares jump after Novo Nordisk deal draws traders

Veru shares jump after Novo Nordisk deal draws traders

Veru shares soared 112% to $4.78 after announcing Novo Nordisk will supply Wegovy at no charge for Veru’s Phase 2b obesity trial, with Veru retaining global rights to enobosarm but granting Novo a right of first negotiation; analysts called the deal a “significant event” and kept $24–$25 targets, while Veru warned trial risks and reimbursement challenges remain.
CRISPR Therapeutics Jumps 12% in New York Trading

CRISPR Therapeutics Jumps 12% in New York Trading

CRISPR Therapeutics shares soared 11.7% to $58.15 after presenting at the Jefferies Global Healthcare Conference, with sector momentum lifting gene-editing stocks and the SPDR S&P Biotech ETF up 3.0%. Casgevy, its key sickle cell therapy, posted $43 million Q1 revenue, but a $122.9 million net loss and biotech risks mean the rally hinges on investor appetite and upcoming clinical updates.
AT&T falls as SpaceX threat renews broadband concerns

AT&T falls as SpaceX threat renews broadband concerns

AT&T shares plunged 3.7% to $22.69 after Oppenheimer downgraded the stock, warning SpaceX’s Starlink could disrupt the $1.6 trillion U.S. communications market and threaten broadband and mobile subscriber growth; the drop came as the Supreme Court upheld FCC fines against AT&T and as SpaceX moves toward a public listing, intensifying investor focus on broadband competition.
High demand wipes out U.S. Mint $5,370 gold coin in minutes

High demand wipes out U.S. Mint $5,370 gold coin in minutes

The U.S. Mint’s new $5,370 one-ounce American Eagle gold coin sold out in under two minutes, highlighting surging demand for physical gold investment, which Metals Focus says will overtake jewelry as the top gold demand driver this year; spot gold rose 1.7% to $4,505.35, but analysts warn high rates and a stronger dollar could pressure prices and premiums.
4 June 2026
PVH Drops Hard as Calvin Klein Parent Issues Warning

PVH Drops Hard as Calvin Klein Parent Issues Warning

PVH shares plunged 21% after the company slashed its annual sales outlook, blaming the Middle East conflict for a 5% EMEA revenue drop; despite beating first-quarter earnings estimates, the warning erased over a fifth of PVH’s market value as investors focused on EMEA demand risks, with the region making up 47% of sales.
4 June 2026
Redwire Stock Gains After Space-Strawberry Announcement, More Ahead

Redwire Stock Gains After Space-Strawberry Announcement, More Ahead

Redwire shares soared 14.6% to $21.33 after announcing a contract with Astrobiome Space for crop research on the ISS, marking the first commercial flight of its Greenhouse system; contract value was undisclosed, leaving investors to weigh the near-term financial impact as Redwire works to convert a record $498.1 million backlog into revenue following a recent Jefferies downgrade to Hold.
1 53 54 55 56 57 2,078

Stock Market Today

  • Vitalhub Stock Sees Mixed Analyst Price Target Adjustments Reflecting Growth and Margin Updates
    June 17, 2026, 9:00 PM EDT. Vitalhub Inc (TSX:VHI) faces mixed analyst revisions with price targets adjusted down but core valuation unchanged. Stifel cut its price target by CA$2.50, reflecting increased caution around execution risks and growth timelines. RBC Capital also lowered its target by CA$1, signaling tempered return expectations despite maintaining confidence in Vitalhub's business model. The consensus fair value estimate stays steady at CA$12.33, with upward revisions to revenue growth assumptions (from 9.83% to 13.05%) offset by lower net profit margin forecasts (from 18.16% to 16.65%). The future price-to-earnings (P/E) multiple and discount rates saw minimal changes, suggesting model fine-tuning rather than a fundamental shift. Analysts' focus remains on execution risks balanced against growth potential, keeping Vitalhub actively tracked by prominent Canadian brokers.

Latest articles

Wall Street Slips After Hours, Fed Flags Rate Risk

Wall Street Slips After Hours, Fed Flags Rate Risk

18 June 2026
S&P 500 plunged 1.2%, Nasdaq 1.3%, and Dow 507 points after the Fed held rates steady but signaled a possible hike, raising its 2026 rate forecast to 3.8% and PCE inflation projection to 3.6%; all 11 S&P sectors fell, megacap tech stocks slumped, and after-hours index ETFs stayed lower as traders face a shortened week before Juneteenth.
Meta Drops as Fed Signal Hurts Nasdaq, AI Bet Draws Scrutiny

Meta Drops as Fed Signal Hurts Nasdaq, AI Bet Draws Scrutiny

18 June 2026
Meta plunged 5.5% to $567.58, underperforming the Nasdaq, after the Federal Reserve signaled possible future rate hikes and a key Meta executive tied to AI-agent work departed, raising pressure on Meta to prove its costly AI investments can deliver returns as higher rates threaten future profit values.
Microsoft Drops as AI Spend Concerns, Fed Rate News Hit Shares

Microsoft Drops as AI Spend Concerns, Fed Rate News Hit Shares

18 June 2026
Microsoft plunged 3.8% to $378.91—outpacing the Nasdaq’s 1.3% drop—as investors reacted to a possible 2026 Fed rate hike and mounting scrutiny over Microsoft’s soaring AI spending, with capex projected at $190 billion for 2026 and a shareholder lawsuit alleging inadequate Azure growth disclosures adding further pressure.
Go toTop